EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 49 filers reported holding EDGEWISE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $232,088 | -15.8% | 40,504 | +13.8% | 0.00% | – |
Q2 2023 | $275,729 | +31.3% | 35,578 | +13.4% | 0.00% | – |
Q1 2023 | $210,000 | +96674.2% | 31,380 | +29.0% | 0.00% | – |
Q4 2022 | $217 | -99.9% | 24,317 | +22.8% | 0.00% | – |
Q3 2022 | $195,000 | +16.1% | 19,797 | -6.2% | 0.00% | – |
Q2 2022 | $168,000 | -36.1% | 21,109 | -22.3% | 0.00% | – |
Q1 2022 | $263,000 | -22.0% | 27,166 | +23.4% | 0.00% | – |
Q4 2021 | $337,000 | +171.8% | 22,010 | +194.3% | 0.00% | – |
Q3 2021 | $124,000 | -42.6% | 7,479 | -26.1% | 0.00% | – |
Q2 2021 | $216,000 | – | 10,123 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,553,661 | $15,071,000 | 7.43% |
Cormorant Asset Management, LP | 4,682,874 | $45,424,000 | 3.49% |
Novo Holdings A/S | 5,587,207 | $54,196,000 | 2.86% |
Orbimed Advisors | 13,944,680 | $135,263,000 | 2.19% |
Opaleye Management Inc. | 303,000 | $2,939,000 | 0.91% |
DAFNA Capital Management LLC | 356,750 | $3,460,000 | 0.90% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $38,151,000 | 0.85% |
EcoR1 Capital, LLC | 2,359,808 | $22,890,000 | 0.72% |
RA Capital Management | 2,613,623 | $25,352,000 | 0.55% |
HighVista Strategies LLC | 59,733 | $579,000 | 0.37% |